These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 22525784)
1. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis. Kymionis GD; Kankariya VP; Kontadakis GA Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784 [TBL] [Abstract][Full Text] [Related]
2. Treatment of superior limbic keratoconjunctivitis with topical tacrolimus 0.03% ointment. Kymionis GD; Klados NE; Kontadakis GA; Mikropoulos DG Cornea; 2013 Nov; 32(11):1499-501. PubMed ID: 23770977 [TBL] [Abstract][Full Text] [Related]
3. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis. Kymionis GD; Goldman D; Ide T; Yoo SH Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583 [TBL] [Abstract][Full Text] [Related]
4. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R; Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341 [TBL] [Abstract][Full Text] [Related]
5. Topical Tacrolimus 0.03% for Maintenance Therapy in Steroid-Dependent, Recurrent Phlyctenular Keratoconjunctivitis. Yoon CH; Kim MK; Oh JY Cornea; 2018 Feb; 37(2):168-171. PubMed ID: 29309358 [TBL] [Abstract][Full Text] [Related]
6. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis. Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977 [TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Joseph MA; Kaufman HE; Insler M Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797 [TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature. García DP; Alperte JI; Cristóbal JA; Mateo Orobia AJ; Muro EM; Valyi Z; Del Rio BJ; Arnao MR Cornea; 2011 Apr; 30(4):462-5. PubMed ID: 20861732 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. Al-Amri AM Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439 [TBL] [Abstract][Full Text] [Related]
18. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. Lee YJ; Kim SW; Seo KY Am J Ophthalmol; 2013 May; 155(5):804-13. PubMed ID: 23394907 [TBL] [Abstract][Full Text] [Related]
19. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis. Tzu JH; Utine CA; Stern ME; Akpek EK Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107 [TBL] [Abstract][Full Text] [Related]
20. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Virtanen HM; Reitamo S; Kari M; Kari O Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]